Myovant sciences sec filings
WebView PDF Filing TEXT-EXTRACT 2 filename2.txt United States securities and exchange commission logo December 21, 2024 Matthew Goodman Partner Sullivan & Cromwell ... Myovant Sciences Ltd ... WebMar 31, 2024 · 10-K. Filing Date. May 24, 2024. Document Date. Mar 31, 2024. Form Description. Annual report which provides a comprehensive overview of the company for the past year. Filing Group. Annual Filings.
Myovant sciences sec filings
Did you know?
WebMar 10, 2024 · Since its formation in 2016, Myovant has secured five regulatory approvals in the United States and Europe for its products ORGOVYX® and MYFEMBREE® in hormone … WebMar 6, 2024 · Myovant Sciences Ltd. (Name of Issuer) Common Shares, par value $0.000017727 per share (Title of Class of Securities) G637AM102 (CUSIP Number) Tsutomu Nakagawa Executive Officer, Senior...
WebMyovant Sciences Ltd. (Subject) CIK: 0001679082 (see all company filings) IRS No.: 000000000 State of Incorp.:CA Fiscal Year End: 0331 Type: SC 13G Act: 34 ... WebDec 18, 2024 · SEC Filing Myovant Sciences Ltd. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 18, 2024 Myovant Sciences Ltd. (Exact name of …
WebApr 11, 2024 · Shares of NYSE MYOV opened at $26.98 on Tuesday. The firm’s 50 day simple moving average is $26.96 and its 200-day simple moving average is $26.25. Myovant Sciences has a 12 month low of $7.67 ... WebNov 15, 2024 · Myovant publishes two-year data from the SPIRIT long-term extension study to support the sNDA filing for Myfembree in endometriosis. PDUFA date for the sNDA filing is May 6th, 2024. Richter...
WebMar 10, 2024 · Sumitovant has acquired all outstanding shares of Myovant not already owned by Sumitovant in an all-cash deal with a total transaction value of approximately $1.7 billion. With the completion of the acquisition, Myovant will be delisted from the New York Stock Exchange, and its shares will no longer be publicly traded.
WebDec 31, 2024 · SEC filings and transcripts for Myovant Sciences Ltd, including financials, news, proxies, indentures, prospectuses, and credit agreements ... 5 Myovant Sciences Ltd Expert Interviews, now on BamSEC. Powered by Tegus. See … elisabeth 1 buchelisabeth 21WebMyovant is developing innovative medicines that hold promise to improve people’s lives. View our pipeline TRANSFORMATIVE ADVOCACY We’re partnering with cross-sector … fopen file wWebMar 10, 2024 · Myovant and its partners continue to file for additional indications of its products, as well as advance development of its pipeline. Myovant is a wholly owned subsidiary of Sumitovant... f open newlineWebMYOVANT SCIENCES LTD., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of Debt Securities filed by Myovant Sciences Ltd. on November 13th, 2024 elisabeth 2 anniversaireWebThe Participant expressly acknowledges that the Participant is solely responsible for filing any such Section 83(b) election with the appropriate governmental authorities, irrespective of the fact that such election is also delivered to the Parent. ... “These shares have been issued pursuant to the Myovant Sciences Ltd. 2016 Equity Incentive ... elisabeth 20th anniversaryWebView PDF Filing TEXT-EXTRACT 2 filename2.txt United States securities and exchange commission logo December 21, 2024 Matthew Goodman Partner Sullivan & Cromwell ... elisabeth 2 astrotheme